Frank Anderson

6.3k total citations · 2 hit papers
64 papers, 3.7k citations indexed

About

Frank Anderson is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Frank Anderson has authored 64 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 23 papers in Epidemiology and 21 papers in Hepatology. Recurrent topics in Frank Anderson's work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (12 papers) and Pancreatitis Pathology and Treatment (10 papers). Frank Anderson is often cited by papers focused on Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (12 papers) and Pancreatitis Pathology and Treatment (10 papers). Frank Anderson collaborates with scholars based in Canada, South Africa and United States. Frank Anderson's co-authors include Brian G. Feagan, Gary Wild, Paul Rutgeerts, Michael A. Kamm, William Y. Chey, Jane E. Onken, Bruce E. Sands, Joshua R. Korzenik, P Marsters and Daniel Rachmilewitz and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Frank Anderson

62 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

2004 1.6k citations Bruce E. Sands, Frank Anderson et al. New England Journal of Medicine profile →
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

2010 515 citations Stuart C. Gordon, Frank Anderson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Anderson Canada	23	2.3k	1.5k	1.3k	969	480	64	3.7k
Ambrogio Orlando Italy	31	2.7k 1.2×	2.5k 1.7×	1.2k 0.9×	1.2k 1.2×	591 1.2×	152	4.5k
Greg Galler United States	9	1.7k 0.8×	1.1k 0.7×	1.2k 0.9×	381 0.4×	195 0.4×	13	2.4k
Kenneth R. Falchuk United States	28	1.2k 0.5×	1.1k 0.7×	287 0.2×	984 1.0×	509 1.1×	69	3.0k
Gottfried Novacek Austria	26	1.6k 0.7×	1.8k 1.2×	213 0.2×	1.2k 1.2×	387 0.8×	103	3.3k
Eirini I. Rigopoulou Greece	36	2.2k 1.0×	343 0.2×	2.3k 1.7×	755 0.8×	574 1.2×	117	3.6k
Talat Bessissow Canada	29	1.8k 0.8×	2.0k 1.4×	226 0.2×	1.1k 1.1×	389 0.8×	204	3.0k
Jordi Guardiola Spain	30	986 0.4×	844 0.6×	481 0.4×	966 1.0×	333 0.7×	143	2.6k
Elena Ricart Spain	38	2.7k 1.2×	3.5k 2.3×	303 0.2×	2.0k 2.1×	772 1.6×	121	5.0k
J F Colombel United States	29	1.7k 0.7×	2.2k 1.5×	194 0.1×	1.4k 1.4×	797 1.7×	148	3.6k
Alfredo Papa Italy	36	1.4k 0.6×	1.9k 1.3×	194 0.1×	1.4k 1.4×	673 1.4×	161	3.9k

Countries citing papers authored by Frank Anderson

Since Specialization

Citations

This map shows the geographic impact of Frank Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Anderson more than expected).

Fields of papers citing papers by Frank Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Anderson. The network helps show where Frank Anderson may publish in the future.

Co-authorship network of co-authors of Frank Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Anderson. A scholar is included among the top collaborators of Frank Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Anderson. Frank Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nyquist, Sarah K., Alveera Singh, Ian Mbano, et al.. (2021). HIV infection drives interferon signaling within intestinal SARS-CoV-2 target cells. JCI Insight. 6(16). 5 indexed citations

Singh, Alveera, Kavidha Reddy, Ntombifuthi Mthabela, et al.. (2021). Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection. JCI Insight. 6(22). 15 indexed citations

Sartorius, Benn, et al.. (2017). The spectrum of gastric cancer as seen in a large quaternary hospital in KwaZulu-Natal, South Africa. South African Medical Journal. 107(2). 130–130. 6 indexed citations

Federico, Carole A., Mel Krajden, Eric M. Yoshida, et al.. (2011). Health utilities and psychometric quality of life in patients with early‐ and late‐stage hepatitis C virus infection. Journal of Gastroenterology and Hepatology. 27(1). 149–157. 61 indexed citations

John‐Baptiste, Ava, George Tomlinson, Mel Krajden, et al.. (2009). Sustained Responders Have Better Quality of Life and Productivity Compared With Treatment Failures Long After Antiviral Therapy for Hepatitis C. The American Journal of Gastroenterology. 104(10). 2439–2448. 72 indexed citations

Thomson, S R, et al.. (2009). Preduodenal portal vein: a potential laparoscopic cholecystectomy nightmare.. PubMed. 47(1). 17–8. 1 indexed citations

Krajden, Mel, et al.. (2009). Does cirrhosis affect quality of life in hepatitis C virus‐infected patients?. Liver International. 29(3). 449–458. 24 indexed citations

Kaita, K., Eric M. Yoshida, Derek Kunimoto, et al.. (2007). [127] Phil PROOF OF CONCEPT STUDY OF CELGOSIVIR IN COMBINATION WITH PEGINTERFERON o-2b AND RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE-1 NON-RESPONDER PATIENTS. Journal of Hepatology. 46. S56–S57. 19 indexed citations

Sherman, Morris, Eric M. Yoshida, Marc Deschênes, et al.. (2006). Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Gut. 55(11). 1631–1638. 65 indexed citations

10.

Buccimazza, Ines, et al.. (2006). Isolated main pancreatic duct injuries spectrum and management. The American Journal of Surgery. 191(4). 448–452. 43 indexed citations

11.

Terrault, Norah A., Jean–Michel Pawlotsky, John G. McHutchison, et al.. (2005). Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy. Journal of Viral Hepatitis. 12(5). 465–472. 21 indexed citations

12.

Sands, Bruce E., Frank Anderson, Çharles N. Bernstein, et al.. (2004). Infliximab Maintenance Therapy for Fistulizing Crohn's Disease. New England Journal of Medicine. 350(9). 876–885. 1607 indexed citations breakdown →

13.

Lai, Ching‐Lung, Rosmawati Mohamed, Hans Van Vlierberghe, et al.. (2002). Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology. 123(6). 1831–1838. 226 indexed citations

14.

Yacyshyn, Bruce, W.Y. Chey, J S Goff, et al.. (2000). Double-blinded, randomized, placebo-controlled trial of the remission inducing and steroid sparing properties of two schedules of ISIS 2302 (ICAM-1 antisense) in active, steroid-dependent crohn's disease. Gastroenterology. 118(4). A570–A570. 9 indexed citations

15.

Yoshida, Eric M., et al.. (1997). ALTERATION OF THE DISMAL NATURAL HISTORY OF FIBROSING CHOLESTATIC HEPATITIS SECONDARY TO HEPATITIS B VIRUS WITH THE USE OF LAMIVUDINE. Transplantation. 64(6). 926–928. 43 indexed citations

16.

Zeng, Lirong & Frank Anderson. (1996). Seasonal Change in the Exacerbations of Crohn's Disease. Scandinavian Journal of Gastroenterology. 31(1). 79–82. 46 indexed citations

17.

Yoshida, Eric M., et al.. (1994). ATTEMPTED RESOLUTION OF ACUTE RECURRENT HEPATITIS B IN A TRANSPLANTED LIVER ALLOGRAFT BY THE ADMINISTRATION OF GANCICLOVIR. Transplantation. 58(8). 956–958. 12 indexed citations

18.

Nanji, Amin A. & Frank Anderson. (1985). Sensitivity and Specificity of Liver Function Tests in the Detection of Parenteral Nutrition‐Associated Cholestasis. Journal of Parenteral and Enteral Nutrition. 9(3). 307–308. 46 indexed citations

19.

Nanji, Amin A. & Frank Anderson. (1984). Relationship between Serum Albumin and Parenteral Nutrition‐Associated Cholestasis. Journal of Parenteral and Enteral Nutrition. 8(4). 438–439. 8 indexed citations

20.

Anderson, Frank, et al.. (1981). An atlas of overdentures and attachments. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact